Gleneagles Global Hospitals is a leading player in the healthcare industry, offering a vast network of multi-specialty hospitals and comprehensive transplant services across major Indian cities. Founded in 1998 as Ravindranath GE Medical Associates Private Ltd, the group operates five hospitals and three feeder centers, currently managing approximately 1,100 operational beds across Hyderabad, Bangalore, Chennai, and Mumbai. With ambitious expansion plans, the company aims to increase its capacity to around 1,900 beds in the next five years.
One of the key distinguishing factors of Gleneagles Global Hospitals is its focus on transplant services, including those for liver, heart, lung, kidney, and bone marrow. The company received a significant $4.26M Series B investment on 27 August 2015, underlining its appeal to investors keen on the potential of the healthcare market in India. The hospital's commitment to pioneering healthcare excellence coupled with its strategic expansion plans positions it as an attractive proposition for potential venture capital interests looking to invest in the healthcare industry.
No recent news or press coverage available for Gleneagles Global Hospitals.